Abstract
To the Editor: In the Clinical Practice review of nonspecific low back pain by Chiarotto and Koes (May 5 issue),1 the authors provide brief mention of specific causes to consider in screening for red flags, such as cancer and spinal fracture. However, they miss an opportunity to provide similar details about screening for axial spondyloarthritis. Although most patients with back pain have nonspecific low back pain, it is critical that providers be able to screen effectively for other specific causes, including axial spondyloarthritis. The authors mention this to some degree, but given the unacceptably long diagnostic delay that is common.
Original language | English (US) |
---|---|
Pages (from-to) | 478-480 |
Number of pages | 3 |
Journal | New England Journal of Medicine |
Volume | 387 |
Issue number | 5 |
DOIs | |
State | Published - Aug 4 2022 |
Funding
Ms. Passalent reports receiving consulting fees, speaking fees, and grant support from AbbVie, Janssen, Novartis, and UCB; Dr. Inman, receiving consulting fees, speaking fees, and grant support from AbbVie, Amgen, Janssen, Eli Lilly, and Novartis; and Dr. Haroon, receiving consulting fees from AbbVie, Janssen, Eli Lilly, Novartis, and UCB. No other potential conflict of interest relevant to this letter was reported.
ASJC Scopus subject areas
- General Medicine